Spot on. It's always about the FDA and CE approvals. Anything else in between, except for Sleep Apnea related, are just temporary fluctuation.
The management must have known about the low incidence number of Croup to be included in the US regulatory filing. Why and why are wasting time waiting for the results, since it doesn't really matter?
That's a question for Tony Keating tomorrow.
Spot on. It's always about the FDA and CE approvals. Anything...
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.001(1.82%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.6¢ | $240.9K | 4.194M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 361732 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 183839 | 1 |
View Market Depth
| Last trade - 14.08pm 22/04/2021 (20 minute delay) ? |
| RAP (ASX) Chart |
Day chart unavailable
